| Ident. | Authors (with country if any) | Title |
|---|
| 000001 (2021) |
Daniel G. Dauner ; Kim Nichols Dauner | Summary of adverse drug events for hydroxychloroquine, azithromycin, and chloroquine during the COVID-19 pandemic. |
| 000002 (2021) |
Fabricio Souza Neves [Brésil] | Correlation of the rise and fall in COVID-19 cases with the social isolation index and early outpatient treatment with hydroxychloroquine and chloroquine in the state of Santa Catarina, southern Brazil: A retrospective analysis. |
| 000004 (2021) |
Stéphane Honoré [France] ; Philippe Gautret [France] | Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients. |
| 000005 (2021) |
Elisa Baranski Lamback [Brésil] ; Monica Amorim De Oliveira [Brésil] ; Andrea Ferreira Haddad [Brésil] ; André Filipe Marcondes Vieira [Brésil] ; Armando Leão Ferreira Neto [Brésil] ; Taciana Da Silva Maia [Brésil] ; Juliana De Rezende Chrisman [Brésil] ; Pedro Pimenta De Mello Spineti [Brésil] ; Marco Antonio De Mattos [Brésil] ; Eduardo Costa [Brésil] | Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19. |
| 000008 (2021) |
Sandip Mukhopadhyay [Inde] ; Suhrita Paul [Inde] ; Basabdatta Samanta [Inde] | Hydroxychloroquine in the prophylaxis of COVID 19: A survey of safety on the healthcare workers in India. |
| 000009 (2021) |
Rashed Noor [Bangladesh] | Antiviral drugs against severe acute respiratory syndrome coronavirus 2 infection triggering the coronavirus disease-19 pandemic. |
| 000010 (2021) |
Nicole Fagan [Irlande (pays)] ; Nekma Meah [Australie] ; Katherine York [Afrique du Sud] ; Laita Bokhari [Australie] ; Godfrey Fletcher [Irlande (pays)] ; Gang Chen [Australie] ; Desmond J. Tobin [Irlande (pays)] ; Andrew Messenger [Royaume-Uni] ; Alan D. Irvine [Irlande (pays)] ; Rodney Sinclair [Australie] ; Dmitri Wall [Irlande (pays)] | Shedding light on therapeutics in alopecia and their relevance to COVID-19. |
| 000011 (2021) |
Matthieu Million [France] ; Audrey Giraud-Gatineau [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Philippe Gautret [France] ; Didier Raoult [France] | Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin. |
| 000012 (2021) |
Sourabh Agstam [Inde] ; Ashutosh Yadav [Inde] ; Praveen Kumar-M [Inde] ; Ankur Gupta [Inde] | Hydroxychloroquine and QTc prolongation in patients with COVID-19: A systematic review and meta-analysis. |
| 000014 (2021) |
Julio Echarte-Morales [Espagne] ; Carlos Minguito-Carazo [Espagne] ; Samuel Del Castillo-García [Espagne] ; Javier Borrego-Rodríguez [Espagne] ; Miguel Rodríguez-Santamarta [Espagne] ; Enrique Sánchez-Mu Oz [Espagne] ; Rubén Bergel-García [Espagne] ; Clea González-Maniega [Espagne] ; Silvia Prieto-González [Espagne] ; Paula Menéndez-Suarez [Espagne] ; Elena Tundidor-Sanz [Espagne] ; Tomás Benito-González [Espagne] ; Felipe Fernández-Vázquez [Espagne] | Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19. |
| 000015 (2021) |
Roberto Ariel Abelda O Zu Iga [Mexique] ; Silvia Mercedes Coca [Mexique] ; Giuliana Florencia Abelda O [Mexique] ; Ruth Ana María González-Villoria [Mexique] | Clinical effectiveness of drugs in hospitalized patients with COVID-19: a systematic review and meta-analysis. |
| 000016 (2021) |
Claudia Lilli ; Annibale Biggeri [Italie] ; Chiara Zingaretti ; Bernadette Vertogen ; Valeria Frassineti ; Roberto Vespignani ; Veruska Grossi ; Caterina Florescu ; Laura Matteucci ; Chiara Pazzi ; Alberto Bongiovanni ; Francesco Limarzi ; Valentina Fausti ; Lucia Bertoni ; Caterina Donati ; Francesca Galardi ; Nicola Gentili ; Francesco Mazza ; Giovanni Martinelli ; Oriana Nanni | Is it possible to conduct clinical trials during a pandemic? The example of a trial of hydroxychloroquine. |
| 000017 (2021) |
Atiya R. Faruqui [Inde] ; Denis Xavier [Inde] ; Sandhya K. Kamat [Inde] ; Sujith J. Chandy [Inde] ; Bikash Medhi [Inde] ; Raakhi K. Tripathi [Inde] ; Yashashri C. Shetty [Inde] ; John Michael Raj [Inde] ; Sandeep Kaushal [Inde] ; S. Balakrishnan [Inde] ; Shubham Atal [Inde] ; Santanu K. Tripathi [Inde] ; Dinesh K. Badyal [Inde] ; Harihar Dikshit [Inde] ; Sukalyan Saha Roy [Inde] ; Niyati Trivedi [Inde] ; Suparna Chatterjee [Inde] ; Chetna Desai [Inde] ; C D Tripathi [Inde] ; Nirmala N. Rege [Inde] ; Pooja Gupta [Inde] ; R. Raveendran [Inde] ; Rajni Kaul [Inde] ; Nilima A. Kshirsagar [Inde] | Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis. |
| 000018 (2021) |
Amaya García-Fernández [Espagne] ; Pablo Ramos-Ruiz [Espagne] ; Alicia Ibá Ez-Criado [Espagne] ; Scar Moreno-Pérez [Espagne] ; Cristina Cambra-Poveda [Espagne] ; Juan Gabriel Martínez-Martínez [Espagne] | [Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients]. |
| 000021 (2021) |
Pierre Ekobena [Suisse] ; Anton Ivanyuk [Suisse] ; Françoise Livio [Suisse] | [Pharmacovigilance update]. |
| 000023 (2021) |
Consuelo Luna-Mu Oz [Pérou] ; Giuliana Reyes-Florian [Pérou] ; Martin Seminario-Aliaga [Pérou] ; Angie Stapleton-Herbozo [Pérou] ; Lucy E. Correa-L Pez [Pérou] ; Dante M. Qui Ones-Laveriano [Pérou] | [Pediatric inflammatory multisystem syndrome associated with COVID-19: A report of 10 cases in a Peruvian hospital]. |
| 000025 (2021) |
Francisco Tejada Cifuentes [Espagne] ; Ángeles Lloret Callejo [Espagne] ; María José Tirado Peláez [Espagne] ; Olga Rubio Pulido [Espagne] ; Marta Ruiz-Morote Arag N [Espagne] ; Rocío Fernández Urrusuno [Espagne] ; María Isabel Mu Oz Carreras [Espagne] ; María Isabel Méndez Esteban [Espagne] ; Victoria Maestre Sánchez [Espagne] ; Antonio García Bonilla [Espagne] ; José Manuel Paredero Dominguez [Espagne] ; Virginia Arroyo Pineda [Espagne] ; Esther Marco Tej N [Espagne] ; Gregorio Romero Candel [Espagne] ; Ana Isabel Fernández Marchante [Espagne] ; José Marco Del Rio [Espagne] ; Teresa Ortiz Martín [Espagne] ; Piedad L Pez Sánchez [Espagne] | [Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine]. |
| 000026 (2021) |
M. Bovet [Allemagne] ; D. Wadsack [Allemagne] ; F. Kosely [Allemagne] ; W. Zink [Allemagne] ; R. Zahn [Allemagne] | [Fatal course of COVID-19 despite IL-6 receptor blockade in cytokine storm : Perimyocarditis and coagulopathy after administration of tocilizumab]. |
| 000029 (2021) |
Maurizio Koch | [2020: Evidence-Based Medicine odyssey. The fall and rise of evidence-based medicine in the year of coronavirus.] |
| 000030 (2021) |
Rujittika Mungmunpuntipantip [Thaïlande] ; Viroj Wiwanitkit [Inde] | Zebra-like bodies in COVID-19, hydroxychloroquine, and acute renal injury. |
| 000031 (2021) |
Hülya Gamze Çelik [Turquie] ; Iran Keske [Turquie] ; Ülker Ener [Turquie] ; Müge Tekba [Turquie] ; Mahir Kapmaz [Turquie] ; Krü Taylan Ahin [Turquie] ; Asl Özy Ld R M [Turquie] ; Saide Aytekin [Turquie] ; Vedat Aytekin [Turquie] ; Önder Ergönül [Turquie] | Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic? |
| 000032 (2021) |
Yesim Oymak ; Tuba H. Karapinar ; Lker Devrim [Turquie] | Why G6PD Deficiency Should Be Screened Before COVID-19 Treatment With Hydroxychloroquine? |
| 000033 (2021) |
Dania Altulea [Pays-Bas] ; Sjors Maassen [Pays-Bas] ; Maksim V. Baranov [Pays-Bas] ; Geert Van Den Bogaart [Pays-Bas] | What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology. |
| 000036 (2021) |
Theodore L. Caputi [Royaume-Uni] | What cannabis can learn from Covid: Hydroxychloroquine research suggests the next step for medical cannabis research. |
| 000037 (2021) |
Isabel Fambuena-Muedra [Espagne] ; Marta Jiménez-García [Belgique] ; Sarah Hershko [Belgique] ; Irene Altemir-G Mez [Espagne] ; Ana Tobarra-L Pez [Espagne] | What can visual caregivers expect with patients treated for SARS-CoV-2? An analysis of ongoing clinical trials and ocular side effects. |
| 000041 (2021) |
Keenan M. Mahan [États-Unis] ; Bryan D. Hayes [États-Unis] ; Crystal M. North [États-Unis] ; Justin S. Becker [États-Unis] ; Andrew Z. Fenves [États-Unis] ; Guibenson Hyppolite [États-Unis] ; Sara Khosrowjerdi [États-Unis] ; Daniel Sinden [États-Unis] ; Dana A. Stearns [États-Unis] | Utility of Hypertonic Saline and Diazepam in COVID-19-Related Hydroxychloroquine Toxicity. |
| 000042 (2021) |
Amaya García-Fernández [Espagne] ; Pablo Ramos-Ruiz [Espagne] ; Alicia Ibá Ez-Criado [Espagne] ; Scar Moreno-Pérez [Espagne] ; Cristina Cambra-Poveda [Espagne] ; Juan Gabriel Martínez-Martínez [Espagne] | Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients. |
| 000044 (2021) |
Jason D. Goldman [États-Unis] ; George Diaz [États-Unis] ; Walter J. Urba [États-Unis] | Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature. |
| 000045 (2021) |
Mudit Agarwal [Inde] ; Piyush Ranjan [Inde] ; Ankit Mittal [Inde] ; Upendra Baitha [Inde] | Use of hydroxychloroquine for pre-exposure prophylaxis in COVID 19: debate and suggested future course. |
| 000046 (2021) |
Paulo Roberto Bignardi [Brésil] ; Carolina Santos Vengrus [Brésil] ; Bruno Matos Aquino [Brésil] ; Alcindo Cerci Neto [Brésil] | Use of hydroxychloroquine and chloroquine in patients with COVID-19: a meta-analysis of randomized clinical trials. |
| 000048 (2021) |
Samah Mohamad Lotfy [Égypte] ; Ahmad Abbas [Égypte] ; Waheed Shouman [Égypte] | Use of Hydroxychloroquine in Patients with COVID-19: A Retrospective Observational Study. |
| 000049 (2021) |
Boghuma K. Titanji [États-Unis] ; Monica M. Farley [États-Unis] ; Ashish Mehta [États-Unis] ; Randi Connor-Schuler [États-Unis] ; Abeer Moanna [États-Unis] ; Sushma K. Cribbs [États-Unis] ; Jesse O'Shea [États-Unis] ; Kathryn Desilva [États-Unis] ; Bonnie Chan [États-Unis] ; Alex Edwards [États-Unis] ; Christina Gavegnano [États-Unis] ; Raymond F. Schinazi [États-Unis] ; Vincent C. Marconi [États-Unis] | Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019. |
| 000050 (2021) |
Isabel S. Hernandes [Brésil] ; Haroldo C. Da Silva [Brésil] ; Hélio F. Dos Santos [Brésil] ; Wagner B. De Almeida [Brésil] | Unveiling the Molecular Structure of Antimalarial Drugs Chloroquine and Hydroxychloroquine in Solution through Analysis of 1H NMR Chemical Shifts. |
| 000051 (2021) |
Tahani Bin Ali ; Ghaleb Elyamany ; Maha Nojoom ; Mohamed Alfaki ; Hassan Alahmari ; Abdulwahab Alharthi ; Muwaffak Hijazi ; Atif Alsahari ; Fahad Alabbas ; Abdulnasir Al-Otaibi [Arabie saoudite] | Unusual presentation of COVID-19 in a child complicated by massive acute pulmonary embolism and lung infarction. |
| 000052 (2021) |
Santanu Santra [Inde] ; Santanab Giri [Inde] ; Madhurima Jana [Inde] | Unraveling the origin of interactions of hydroxychloroquine with the receptor-binding domain of SARS-CoV-2 in aqueous medium. |
| 000053 (2021) |
Andrew C. Berry [États-Unis] ; Russell S. Gonnering [États-Unis] ; Ivan Rodriguez [États-Unis] ; Qianying Zhang [États-Unis] ; Bruce B. Berry [États-Unis] | Unfavorable hydroxychloroquine COVID-19 research associated with authors having a history of political party donations. |
| 000055 (2021) |
Tuan V. Nguyen [Australie] | Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load. |
| 000056 (2021) |
Jessica S C. Leung [Hong Kong] ; Maurice M W. Cheng [Nouvelle-Zélande] | Trust in the time of corona: epistemic practice beyond hard evidence. |
| 000057 (2021) |
Nobuaki Mori [Japon] ; Mitsuya Katayama [Japon] ; Shigenari Nukaga [Japon] | Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia. |
| 000061 (2021) |
Neils Ben Quashie [Ghana] ; Nancy Odurowah Duah-Quashie [Ghana] | Treatment of COVID-19 with Chloroquine: Implication for Malaria Chemotherapy Using ACTs in Disease Endemic Countries. |
| 000062 (2021) |
Mohamed A. Taha [États-Unis, Égypte] ; Christian A. Hall [États-Unis] ; Colin J. Shortess [États-Unis] ; Richard F. Rathbone [États-Unis] ; Henry P. Barham [États-Unis] | Treatment Protocol for COVID-19 Based on T2R Phenotype. |
| 000063 (2021) |
Jennie H. Best [États-Unis] ; Amanda M. Kong [États-Unis] ; Emma Kaplan-Lewis [États-Unis] ; Otis W. Brawley [États-Unis] ; Rachel Baden [États-Unis] ; James L. Zazzali [États-Unis] ; Karen S. Miller [États-Unis] ; James Loveless [États-Unis] ; Krutika Jariwala-Parikh [États-Unis] ; Shalini V. Mohan [États-Unis] | Treatment Patterns in US Patients Hospitalized With COVID-19 and Pulmonary Involvement. |
| 000065 (2021) |
Guobing Li [République populaire de Chine, États-Unis] ; Shasha Ruan [République populaire de Chine] ; Xiaolu Zhao [République populaire de Chine] ; Qi Liu [États-Unis] ; Yali Dou [États-Unis] ; Fengbiao Mao [République populaire de Chine] | Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses. |
| 000067 (2021) |
Manel Ben Ali [Arabie saoudite] ; Amor Hedfi [Arabie saoudite] ; Mohammed Almalki [Arabie saoudite] ; Paraskevi K. Karachle [Grèce] ; Fehmi Boufahja [Tunisie] | Toxicity of hydroxychloroquine, a potential treatment for COVID-19, on free-living marine nematodes. |
| 000068 (2021) |
Cassandra Doyno [États-Unis] ; Diana M. Sobieraj [États-Unis] ; William L. Baker [États-Unis] | Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose. |
| 000069 (2021) |
Waqas Aslam [Oman] ; Carla R. Lamb [États-Unis] ; Nadia Ali [États-Unis] | Torsades de pointes in SARS-CoV-2 (COVID-19) pneumonia: medicine reconciliation and careful monitoring of QTc interval may help prevent cardiac complications. |
| 000073 (2021) |
Alexis Lacout [France] ; Valere Lounnas [Allemagne] ; Christian Perronne [France] | Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients. |
| 000075 (2021) |
Sawsan Elgohary [Égypte] ; Aya A. Elkhodiry [Égypte] ; Nada S. Amin [Égypte] ; Ulrike Stein [Allemagne] ; Hend M. El Tayebi [Égypte] | Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients? |
| 000076 (2021) |
Johanna Schneider [Allemagne] ; Bernd Jaenigen [Allemagne] ; Dirk Wagner [Allemagne] ; Siegbert Rieg [Allemagne] ; Daniel Hornuss [Allemagne] ; Paul M. Biever [Allemagne] ; Winfried V. Kern [Allemagne] ; Gerd Walz [Allemagne] | Therapy with lopinavir/ritonavir and hydroxychloroquine is associated with acute kidney injury in COVID-19 patients. |
| 000078 (2021) |
Ales Janda [Allemagne] ; Catharina Schuetz [Allemagne] ; Scott Canna [États-Unis] ; Mark Gorelik [États-Unis] ; Maximilian Heeg [Allemagne] ; Kirsten Minden [Allemagne] ; Claas Hinze [Allemagne] ; Ansgar Schulz [Allemagne] ; Klaus-Michael Debatin [Allemagne] ; Christian M. Hedrich [Royaume-Uni] ; Fabian Speth [Allemagne] | Therapeutic approaches to pediatric COVID-19: an online survey of pediatric rheumatologists. |
| 000079 (2021) |
Nicolas Dauby [Belgique] ; Emmanuel Bottieau [Belgique] | The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment? |
